Clinical Trials Directory

Trials / Completed

CompletedNCT02050451

Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy

A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status, Post-operative Complications, Length of Stay and Readmission Rates in Patients Undergoing Radical Cystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The current study is designed to assess the impact of an enriched oral nutritional shake (Ensure Plus®) to improve the nutritional status and patient outcome after surgery to remove a cancerous bladder (radical cystectomy). Radical cystectomy with urinary diversion using a segment of intestine is the standard of care for invasive bladder cancer. This operation has a high complication rate and several studies have shown that this may be directly related to poor nutrition. The investigators believe that patients who consume an enriched nutritional shake before and after surgery will improve their nutrition status and experience fewer complications, shorter length of stay and less readmissions compared to those who do not. Patients who are scheduled to undergo elective radical cystectomy will be eligible for enrollment. Once enrolled, they will be randomly assigned to one of two groups. One group will be offered Ensure Plus® twice daily for 2 weeks before and 4 weeks after their surgery and the other will be offered a daily over-the-counter multivitamin for the same period of time. The investigators will follow both groups for up to 30 days after their surgery and compare clinical outcomes such as: complication rates, length of stay, readmission rates and mortality as well as measure serum markers of nutrition status and assess changes in body composition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnsure Plus®
DIETARY_SUPPLEMENTMultivitamin

Timeline

Start date
2014-03-01
Primary completion
2016-12-01
Completion
2017-03-01
First posted
2014-01-30
Last updated
2017-03-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02050451. Inclusion in this directory is not an endorsement.